AR and breast neoplasm: However, the positive or negative effects depend on the type of androgen used, e.g., aromatizable testosterone (T) or non-aromatizable dihydrotestosterone (DHT), but also on the ERα and AR status of the breast tumor cell and aromatase activity in the surrounding breast fibroblasts [17].